Prostate Cancer

Cancer Patients May Have Success with Testosterone

Published in Cancer Weekly, May 15th, 1995

Prostate cancer patients have a new option for controlling the tumor's size, thus making it easier for doctors to remove all of the cancerous tissue during surgery.

"In patients with prostate cancer, testosterone-suppressing medications may cause, among other things, shrinkage of the tumor," said Dr. Mark Soloway, chairman of the Department of Urology at the University of Miami School of Medicine, Florida. "This could enhance the surgeon's ability to remove all of the cancerous tissue and make for improved surgical results."

Soloway's information came from what he called the largest prospective, randomized, multi-center study of its kind. He...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-05-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry